Suboptimal Uptake, Retention, and Adherence of Daily Oral Prexposure Prophylaxis Among People With Opioid Use Disorder Receiving Hepatitis C Virus TreatmentOPEN FORUM INFECTIOUS DISEASESIF3.82021-12-295OAAI
Initiation of Low-threshold Buprenorphine in Nontreatment Seeking Patients With Opioid Use Disorder Engaged in Hepatitis C TreatmentJOURNAL OF ADDICTION MEDICINEIF3.22021-02-057OA
Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject DrugsCLINICAL INFECTIOUS DISEASESIF7.32020-02-0388OAAI
Collocation of Buprenorphine with HCV treatment to improve adherence and reduce harm in PWID with HCV: Preliminary data from the ANCHOR studyJOURNAL OF HEPATOLOGYIF332018-04-013PREAI